[Pediatric angiocardiography. Randomized, controlled study of 2 iodinated contrast media: iopromide 300 and ioxaglate 320 mgI/ml].
Thirty-one children were included in a prospective randomized trial comparing a new non-ionic contrast medium, iopromide 300 and the ionic low osmolar contrast medium, ioxaglate 320 mgI/ml in pediatric cardiac catheterisation. There were fewer adverse effects with iopromide but no statistically significant difference was demonstrated in this small population, with a very low incidence of allergoïd reactions; this tendency was confirmed by meta-analysis of the multicentre study.
Amiel
M
M
Revel
D
D
D000790:Angiocardiography; D002675:Child, Preschool; D003287:Contrast Media; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007472:Iohexol / Q000009:adverse effects / Q000031:analogs & derivatives; D007485:Ioxaglic Acid / Q000009:adverse effects; D008297:Male; D016032:Randomized Controlled Trials as Topic
D003287:Contrast Media; D007472:Iohexol; C038192:iopromide; D007485:Ioxaglic Acid
Angiocardiographie pédiatrique. Etude randomisée, contrôlée, de deux produits de contraste iodés: l'iopromide 300 et l'ioxaglate 320 mgI/ml.